Greta Bernier, MD
Colon & Rectal Surgery · Renton, WANPI 1588814198
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Intuitive Surgical at 38.8% of the total. Reporting peaked in 2019 at $6,270 and has fallen 97.4% since, to $166 in 2025.
Across 38 payments — averaging $484.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Covidien LP$6K
- Applied Medical Resources Corporation$4K
- Medtronic$317
- Myriad Genetic Laboratories, Inc.$115
- Pacira Pharmaceuticals Incorporated$102
- plus $128 from 3 others
What the payments were for
- Speaking & faculty fees$9,30051%
- Travel & lodging$3,21217%
- Food & beverage$1,86410%
- Education$4,00022%
- Gifts$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 19 | $7,136 |
| Covidien LP | 8 | $6,325 |
| Applied Medical Resources Corporation | 3 | $4,288 |
| Medtronic | 3 | $317 |
| Myriad Genetic Laboratories, Inc. | 1 | $115 |
| Pacira Pharmaceuticals Incorporated | 1 | $102 |
| Cook Medical LLC | 1 | $69 |
| Stryker | 1 | $40 |
| Olympus America Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,901
- ForceTriad$6,100
- GELPOINT PATH$4,256
- GELPOINT$4,256
- KII FIOS$4,256
- Signia$300
- LigaSure$142
- BRAC CDx$115
- EXPAREL$102
How this compares
$18,410 in reported general payments places this provider in the 85th percentile of 37 colon & rectal surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 11 | $231 |
| Neomycin Sulfate | 25 | $73 |
| Oxycodone Hcl | 24 | $58 |
| Ondansetron Hcl | 25 | $52 |
| Gabapentin | 14 | $42 |
| Metronidazole | 26 | $38 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Renton
- Phillip DeanRenton$89
- Laila RashidiTacoma$805K
- Allison RobinsonBellingham$29K
- Gabriela VargasPuyallup$23K
- Shalini KannegantiTacoma$22K
- Crystal KoernerSeattle$16K
- Anthony SimonsLongview$12K
- Jennifer LeeSeattle$10K
- Jennifer KaplanSeattle$6K
- Darren PollockSeattle$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.